117 reports of this reaction
2.6% of all BUFFERED ASPIRIN reports
#6 most reported adverse reaction
GASTROOESOPHAGEAL REFLUX DISEASE is the #6 most commonly reported adverse reaction for BUFFERED ASPIRIN, manufactured by Lil' Drug Store Products, Inc.. There are 117 FDA adverse event reports linking BUFFERED ASPIRIN to GASTROOESOPHAGEAL REFLUX DISEASE. This represents approximately 2.6% of all 4,540 adverse event reports for this drug.
Patients taking BUFFERED ASPIRIN who experience gastrooesophageal reflux disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GASTROOESOPHAGEAL REFLUX DISEASE is a less commonly reported adverse event for BUFFERED ASPIRIN, but still significant enough to appear in the safety profile.
In addition to gastrooesophageal reflux disease, the following adverse reactions have been reported for BUFFERED ASPIRIN:
The following drugs have also been linked to gastrooesophageal reflux disease in FDA adverse event reports:
GASTROOESOPHAGEAL REFLUX DISEASE has been reported as an adverse event in 117 FDA reports for BUFFERED ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
GASTROOESOPHAGEAL REFLUX DISEASE accounts for approximately 2.6% of all adverse event reports for BUFFERED ASPIRIN, making it a notable side effect.
If you experience gastrooesophageal reflux disease while taking BUFFERED ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.